This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Neuroglee Therapeutics , a startup developingdigitaltherapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to developdigitaltherapeutics for neurodegenerative diseases. Neuroglee gets $2.3
Digitaltherapeutics will rewrite the future of healthcare. Digitaltherapeutics is perhaps the most innovative development in healthcare today and has the potential to dramatically change how care is delivered.
As a venture firm that invests in psychedelics, we receive hundreds of pitches every month from founders developing psychedelic therapeutics. Our fund has invested more than $15 million in companies developing psychedelic therapeutics. Greg Kubin is a partner at PsyMed Ventures and co-host of Business Trip.
We’re excited to share that metaMe Health , a prescription digitaltherapeutics (PDT) company, today announced raising $2.2M metaMe Health is the developer of Regulora®, the first FDA-authorized PDT specifically for abdominal pain associated with Irritable Bowel Syndrome (IBS) in adults. in funding.
BrainCheck , a Houston- and Austin-based company developing cognitive healthcare software to aid physicians in detecting and managing this type of care, raised $10 million in Series B funding to expand its R&D and go-to-market capabilities as it works on new digitaltherapeutics for Alzheimer’s and related dementias.
We’re excited to share that metaMe Health , a prescription digitaltherapeutics (PDT) company, today announced raising $2.2M metaMe Health is the developer of Regulora®, the first FDA-authorized PDT specifically for abdominal pain associated with Irritable Bowel Syndrome (IBS) in adults. in funding.
The post [Eko Health in PR Newswire] Astellas and Eko Health announce agreement to incorporate next generation Eko CORE 500™ Digital Stethoscope into Z1608, an innovative solution under development for heart failure patients built on Welldoc’s proven digitaltherapeutic platform appeared first on OurCrowd Blog.
Neuroglee , a Singapore-based health tech startup, wants to help with a digitaltherapeutic platform created to treat patients in the early stages of the disease. SoftBank Vision Fund 2 leads $100 million Series C in digitaltherapeutics company Biofourmis. million in pre-seed funding. The round was led by Eisai Co.,
David Horwitz, former Global Chief Medical Officer of Johnson and Johnson Diabetes Institute, will help guide strategic and development roadmap. Read more here.
Register Biofourmis , a Sigapore-founded digitaltherapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. Bookmark ( 0 ) Please login to bookmark Username or Email Address Password Remember Me No account yet?
in income replacement grants and mentorship to first-time entrepreneurs, creating 10 new businesses and helping fuel innovation in strategic sectors The New Jersey Economic Development Authority (NJEDA) today announced the inaugural cohort of the New Jersey Innovation Fellows (NJIF) program. First-in-nation program will provide $3.6M
Swing Therapeutics, a digitaltherapeutics startup, has received an FDA breakthrough device designation for their 12-week smartphone-assisted fibromyalgia management program. Swing Therapeutics was founded in 2019 and has raised a total of $9 million in seed funding led by JAZZ Venture Partners. Neuroglee gets $2.3
Medisafe, a leading digitaltherapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug companions for its epilepsy medications. Read more here.
Digital health is a new and challenging space for life sciences. The DTx Alliance’s best practices for digitaltherapeutics advise would-be developers to design products to optimize adoption, engagement and adherence within their target populations. Read more here.
a multi-billion-dollar diabetes franchise previously owned by Johnson & Johnson (JNJ) Scientific Advisory Board will help develop and execute the Company’s strategic roadmap for refining, improving and expanding its digitaltherapeutics platform. Read more here.
10, 2023 /PRNewswire/ — Theranica, a prescribed digitaltherapeutics company developing advanced neuromodulation devices for migraine and other pain conditions, today announced a strategic license and supply agreement with Dr. Reddy’s Laboratories Ltd., NETANYA, Israel, Jan.
Amongst these questions are actual costs of therapies, reimbursement coverage, the commercialisation strategy for psychedelic drug development companies, resource bottlenecks with the therapists’ supply and infrastructure, etc,” they told TechCrunch+. Drug development is very costly, and start-ups are having a harder time raising cash.
startup that offers personalized digitaltherapeutics for women going through menopause, has closed a second round of funding — taking $12 million from lead investor Octopus Ventures, along with participation from U.S.-based Vira Health , a U.K. based VC firm Optum Ventures, as it gears up to hop over the pond.
MedRhythms, a Portland, Maine-based digitaltherapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. How does MedRhythms’ technology work?
Make room for yet another preventative health play: Spotify founder Daniel Ek officially confirmed rumors of his new “health tech” startup, Neko, Friday by quietly kicking off a body scanning service in Sweden (via Tech EU ) after four years of stealthy development.
The FDA is the federal regulatory body in the United States that oversees the development of medical products (e.g. Developing and bringing a product to market will, with the exception of a limited class of products 1 , require explicit FDA marketing approval. We describe the major ones here: Therapeutic Submissions.
We organize all of the trending information in your field so you don't have to. Join 24,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content